These data demonstrated that lymphocytes employ the perforin/granzyme system, and possibly IFNγ, to kill B16 melanoma tumors in the brain following PC blockade, with IFNγ potentially exerting other additional effects that contribute to the ICB-dependent tumor control. The gene discussed is PRF1; the disease is neoplasm.